Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTH1R | Q03431 | 9/20 | 0.66 |
| ▸ | GLP1R | P43220 | 2/20 | 0.64 |
| ▸ | GCGR | P47871 | 1/20 | 0.64 |
| ▸ | GIPR | P48546 | 1/20 | 0.64 |
| ▸ | IL23R | Q5VWK5 | 6/20 | 0.63 |
| ▸ | CCKBR | P32239 | 1/20 | 0.62 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.61 |
| ▸ | GHSR | Q92847 | 2/20 | 0.60 |
| ▸ | NPY2R | P49146 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29467548 | 0.93 | GLP1R (0.62) | PTH1RGLP1RGCGRGIPRIL23R | |
| SCHEMBL21185972 | 0.92 | IL23R (0.65) | IL23RKISS1R | |
| SCHEMBL19731216 | 0.90 | IL23R (0.61) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL16692898 | 0.90 | IL23R (0.61) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL16692899 | 0.90 | IL23R (0.61) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL24172454 | 0.90 | IL23R (0.61) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL16692892 | 0.90 | IL23R (0.61) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL19731206 | 0.90 | IL23R (0.61) | GLP1RGCGRGIPRIL23RKISS1R | |
| SCHEMBL31574199 | 0.90 | PTH1R (0.65) | PTH1RGLP1RGCGRGIPRIL23R | |
| SCHEMBL19731215 | 0.89 | GLP1R (0.61) | GLP1RGCGRGIPRIL23RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240131139-A1 | ADJUVANTED SUBCUTANEOUSLY-ADMINISTERED POLYPEPTIDE SARS-COV-2 VACCINES COMPOSITION AND METHODS | D4 LABS, LLC | 2024-04-25 | — | — | US | disclosed |